These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 9843755)

  • 1. Mechanisms of hepatic toxicity. IV. Pathogenetic mechanisms involved in hepatitis C virus-inducedliver diseases.
    Lau JY
    Am J Physiol; 1998 Dec; 275(6):G1217-20. PubMed ID: 9843755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Virology and pathogenesis of hepatitis C virus recurrence.
    Ramírez S; Pérez-Del-Pulgar S; Forns X
    Liver Transpl; 2008 Oct; 14 Suppl 2():S27-35. PubMed ID: 18825723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis viruses: live and let die.
    Herzer K; Sprinzl MF; Galle PR
    Liver Int; 2007 Apr; 27(3):293-301. PubMed ID: 17355449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathogenesis of hepatitis C virus recurrence in the liver allograft.
    McCaughan GW; Zekry A
    Liver Transpl; 2002 Oct; 8(10 Suppl 1):S7-S13. PubMed ID: 12362292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune-mediated liver damage in chronic hepatitis C.
    Wejstål R
    Scand J Gastroenterol; 1995 Jul; 30(7):609-13. PubMed ID: 7481520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evolution of hepatitis C virus in liver allografts.
    Demetris AJ
    Liver Transpl; 2009 Nov; 15 Suppl 2():S35-41. PubMed ID: 19876940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term longitudinal study of intrahepatic hepatitis C virus replication after liver transplantation.
    Di Martino V; Saurini F; Samuel D; Gigou M; Dussaix E; Reynès M; Bismuth H; Féray C
    Hepatology; 1997 Nov; 26(5):1343-50. PubMed ID: 9362382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural history of recurrent hepatitis C.
    Berenguer M
    Liver Transpl; 2002 Oct; 8(10 Suppl 1):S14-8. PubMed ID: 12362293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of regulatory T-cells during hepatitis C infection: From the acute phase to post-transplantation recurrence.
    Barjon C; Dahlqvist G; Calmus Y; Conti F
    Dig Liver Dis; 2015 Nov; 47(11):913-7. PubMed ID: 26216068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrahepatic cytokine profiles associated with posttransplantation hepatitis C virus-related liver injury.
    Zekry A; Bishop GA; Bowen DG; Gleeson MM; Guney S; Painter DM; McCaughan GW
    Liver Transpl; 2002 Mar; 8(3):292-301. PubMed ID: 11910576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Timing of reinfection and mechanisms of hepatocellular damage in transplanted hepatitis C virus-reinfected liver.
    Ballardini G; De Raffele E; Groff P; Bioulac-Sage P; Grassi A; Ghetti S; Susca M; Strazzabosco M; Bellusci R; Iemmolo RM; Grazi G; Zauli D; Cavallari A; Bianchi FB
    Liver Transpl; 2002 Jan; 8(1):10-20. PubMed ID: 11799480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver transplantation and hepatitis C.
    Willems M; Metselaar HJ; Tilanus HW; Schalm SW; de Man RA
    Transpl Int; 2002 Mar; 15(2-3):61-72. PubMed ID: 11935162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The natural history of recurrent hepatitis C and what influences this.
    Gane EJ
    Liver Transpl; 2008 Oct; 14 Suppl 2():S36-44. PubMed ID: 18825724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of immunosuppression on immunopathogenesis of liver damage in hepatitis C virus-infected recipients following liver transplantation.
    McCaughan GW; Zekry A
    Liver Transpl; 2003 Nov; 9(11):S21-7. PubMed ID: 14586891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathophysiology of hepatitis C virus infection and related liver disease.
    Pawlotsky JM
    Trends Microbiol; 2004 Feb; 12(2):96-102. PubMed ID: 15036326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Graft and viral outcomes in retransplantation for hepatitis C virus recurrence and HCV primary liver transplantation: a case-control study.
    Martí J; De la Serna S; Crespo G; Forns X; Ferrer J; Fondevila C; Navasa M; Fuster J; García-Valdecasas JC
    Clin Transplant; 2014 Jul; 28(7):821-8. PubMed ID: 24806099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of the fas system in hepatitis C virus recurrence after liver transplantation.
    Crespo J; Rivero M; Mayorga M; Fabrega E; Casafont F; Gomez-Fleitas M; Pons-Romero F
    Liver Transpl; 2000 Sep; 6(5):562-9. PubMed ID: 10980054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Initial clinical patterns of hepatitis C virus reinfection after liver transplantation for hepatitis C virus-related cirrhosis.
    Duvoux C; Pawlotsky JM; Cherqui D; Métreau JM; Fagniez PL; Duval J; Dhumeaux D
    Transplant Proc; 1996 Oct; 28(5):2844-5. PubMed ID: 8908093
    [No Abstract]   [Full Text] [Related]  

  • 19. [Immunopathology of chronic liver diseases].
    Meyer zum Büschenfelde KH
    Verh Dtsch Ges Pathol; 1995; 79():186-97. PubMed ID: 8600684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical evidence of immunopathogenetic mechanisms in chronic hepatitis C recurrence after liver transplantation.
    Asanza CG; García-Monzón C; Clemente G; Salcedo M; García-Buey L; García-Iglesias C; Bañares R; Alvarez E; Moreno-Otero R
    Hepatology; 1997 Sep; 26(3):755-63. PubMed ID: 9303509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.